PRIMECAP MANAGEMENT CO/CA/ - ONCOMED PHARMACEUTICALS INC ownership

ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 59 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRIMECAP MANAGEMENT CO/CA/ ownership history of ONCOMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$5,669,000
+37.8%
5,451,400
-1.0%
0.00%
+33.3%
Q4 2018$4,115,000
-65.9%
5,506,300
-3.4%
0.00%
-62.5%
Q3 2018$12,081,000
-6.0%
5,698,700
+2.4%
0.01%
-20.0%
Q2 2018$12,852,000
-27.4%
5,563,700
-0.1%
0.01%
-23.1%
Q1 2018$17,703,000
-22.4%
5,566,900
+0.0%
0.01%
-27.8%
Q4 2017$22,819,000
-9.3%
5,565,600
-0.0%
0.02%
-14.3%
Q3 2017$25,158,000
+36.0%
5,565,900
+0.2%
0.02%
+31.2%
Q2 2017$18,493,000
+5.3%
5,553,600
+191.3%
0.02%0.0%
Q1 2017$17,560,000
+26.5%
1,906,600
+5.9%
0.02%
+14.3%
Q4 2016$13,883,000
-6.8%
1,800,700
+38.2%
0.01%
-6.7%
Q3 2016$14,890,000
+460.6%
1,302,700
+503.7%
0.02%
+400.0%
Q2 2016$2,656,000
+21.7%
215,8000.0%0.00%
+50.0%
Q1 2016$2,182,000
-49.5%
215,800
+12.5%
0.00%
-50.0%
Q4 2015$4,323,000
+36.6%
191,800
+0.5%
0.00%0.0%
Q3 2015$3,165,000
-26.3%
190,8000.0%0.00%0.0%
Q2 2015$4,293,000
-19.3%
190,800
-7.5%
0.00%
-20.0%
Q1 2015$5,318,000
+11.9%
206,293
-5.5%
0.01%0.0%
Q4 2014$4,752,000
+14.9%
218,4000.0%0.01%
+25.0%
Q3 2014$4,134,000
-33.4%
218,400
-18.0%
0.00%
-42.9%
Q2 2014$6,207,000
-45.9%
266,400
-21.8%
0.01%
-46.2%
Q1 2014$11,465,000
+14.0%
340,7000.0%0.01%
+8.3%
Q4 2013$10,057,000
+168.5%
340,700
+39.2%
0.01%
+140.0%
Q3 2013$3,746,000244,7000.01%
Other shareholders

There were no reported owners of ONCOMED PHARMACEUTICALS INC in Q3 2017.

NameSharesValueWeighting ↓
View complete list of ONCOMED PHARMACEUTICALS INC shareholders